Page last updated: 2024-11-04

sotalol and Cruveilhier-Baumgarten Syndrome

sotalol has been researched along with Cruveilhier-Baumgarten Syndrome in 2 studies

Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.

Cruveilhier-Baumgarten Syndrome: Liver cirrhosis with intrahepatic portal obstruction, HYPERTENSION, and patent UMBILICAL VEINS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deflandre, J2
Gillard, V1
Pirotte, J2
el Allaf, D2
Carlier, J2

Other Studies

2 other studies available for sotalol and Cruveilhier-Baumgarten Syndrome

ArticleYear
[Effects of sotalol on blocked suprahepatic pressure in cirrhotic patients].
    Annales de gastroenterologie et d'hepatologie, 1987, Volume: 23, Issue:7

    Topics: Aged; Blood Pressure; Cardiac Output; Cough; Female; Hepatic Veins; Humans; Hypertension, Portal; Li

1987
[The effect of sotalol on cirrhotic portal hypertension. Results of a preliminary study of cardiac and hepatic hemodynamics].
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1986, Volume: 40, Issue:4

    Topics: Adult; Aged; Coronary Circulation; Female; Humans; Hypertension, Portal; Liver Circulation; Liver Ci

1986